Jeito logo.png
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix
16. März 2022 03:00 ET | Jeito Capital
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix Jeito Capital chooses Precirix, a clinical-stage biotechnology company developing precision...